riociguat
UkraineDrugs containing this active substance
-
The drug is used for the treatment of adults with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH) to increase exercise tolerance.
Form: tablets, film-coated
Active substance Dosage riociguat 2.5 mg ATC: C02KX05
Manufacturer: Bayer AG (all manufacturing stages)
-
The drug is used for the treatment of adults with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH) to increase exercise tolerance.
Form: tablets, film-coated
Active substance Dosage riociguat 1.5 mg ATC: C02KX05
Manufacturer: Bayer AG (all manufacturing stages)
-
The drug is used for the treatment of adults with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH) to increase exercise tolerance.
Form: tablets, film-coated
Active substance Dosage riociguat 0.5 mg ATC: C02KX05
Manufacturer: Bayer AG (all manufacturing stages)
-
The drug is used for the treatment of adults with chronic thromboembolic pulmonary hypertension (inoperable or recurrent after surgical intervention), as well as for the treatment of pulmonary arterial hypertension (either as monotherapy or in combination with certain other agents).
Form: tablets, film-coated
Active substance Dosage riociguat 2 mg ATC: C02KX05
Manufacturer: Bayer AG (all manufacturing stages)
-
The drug is used for the treatment of adults with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH) to increase exercise tolerance.
Form: tablets, film-coated
Active substance Dosage riociguat 1 mg ATC: C02KX05
Manufacturer: Bayer AG (all manufacturing stages)